{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:59:24Z","timestamp":1740110364055,"version":"3.37.3"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23390119","24580441","26462806"],"award-info":[{"award-number":["23390119","24580441","26462806"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.antiviral.2016.02.012","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T12:25:22Z","timestamp":1456575922000},"page":"81-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Toll-like receptor 9 ligand D-type oligodeoxynucleotide D35 as a broad inhibitor for influenza A virus replication that is associated with suppression of neuraminidase activity"],"prefix":"10.1016","volume":"129","author":[{"given":"Hiroshi","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Sakoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigefumi","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.02.012_bib1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0021-9673(01)93098-5","article-title":"Analytical study of phosphorothioate analogues of oligodeoxynucleotides using high-performance liquid chromatography","volume":"509","author":"Agrawal","year":"1990","journal-title":"J.\u00a0Chromatogr."},{"key":"10.1016\/j.antiviral.2016.02.012_bib2","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1021\/ja8085643","article-title":"Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations","volume":"131","author":"Amaro","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2016.02.012_bib3","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1021\/ja0723535","article-title":"Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design","volume":"129","author":"Amaro","year":"2007","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2016.02.012_bib4","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1021\/jm800455g","article-title":"A\u00a0novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase","volume":"52","author":"An","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.02.012_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/viro.2002.1503","article-title":"Adenovirus type 37 binds to cell surface sialic acid through a charge-dependent interaction","volume":"302","author":"Arnberg","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.02.012_bib6","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.32.11.1742","article-title":"Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus","volume":"32","author":"Baba","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.02.012_bib7","doi-asserted-by":"crossref","first-page":"21858","DOI":"10.1016\/S0021-9258(17)31882-3","article-title":"Structure and stability of human telomeric sequence","volume":"269","author":"Balagurumoorthy","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.02.012_bib8","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1128\/JVI.78.10.5258-5269.2004","article-title":"Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding","volume":"78","author":"Barman","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib9","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1073\/pnas.161293498","article-title":"Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition","volume":"98","author":"Bauer","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.02.012_bib10","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1074\/jbc.271.10.5698","article-title":"Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide","volume":"271","author":"Bishop","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.02.012_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2165\/11537960-000000000-00000","article-title":"Drugs in development for influenza","volume":"70","author":"Boltz","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2016.02.012_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-3542(01)00215-7","article-title":"Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in\u00a0vitro and is compromised for infectivity and replicative ability in\u00a0vivo","volume":"54","author":"Carr","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.02.012_bib13","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/jvi.67.6.2972-2980.1993","article-title":"Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase","volume":"67","author":"Colman","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbrc.2003.12.041","article-title":"Structural studies of oligonucleotides containing G-quadruplex motifs using AFM","volume":"313","author":"Costa","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2016.02.012_bib15","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1021\/jm00014a001","article-title":"Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections","volume":"38","author":"De Clercq","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.02.012_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.it.2006.12.006","article-title":"Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance","volume":"28","author":"Ehlers","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-3542(94)00064-F","article-title":"Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine","volume":"26","author":"Fennewald","year":"1995","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.02.012_bib18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1128\/AAC.34.5.808","article-title":"Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides","volume":"34","author":"Gao","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.02.012_bib19","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20060401","article-title":"Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation","volume":"203","author":"Guiducci","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2016.02.012_bib20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1177\/135965350701200810","article-title":"Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression","volume":"12","author":"Guzman","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2016.02.012_bib21","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.164.2.944","article-title":"Mechanism and function of a newly identified CpG DNA motif in human primary B cells","volume":"164","author":"Hartmann","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid1502.081031","article-title":"Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08","volume":"15","author":"Hauge","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.02.012_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9343(97)80013-7","article-title":"Prevention and treatment of influenza in immunocompromised patients","volume":"102","author":"Hayden","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.antiviral.2016.02.012_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virol.2007.07.002","article-title":"Enhanced growth of seed viruses for H5N1 influenza vaccines","volume":"366","author":"Horimoto","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.02.012_bib25","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/AAC.35.12.2515","article-title":"Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins","volume":"35","author":"Hosoya","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.02.012_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.antiviral.2009.03.003","article-title":"Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa","volume":"83","author":"Hurt","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.02.012_bib27","doi-asserted-by":"crossref","first-page":"21460","DOI":"10.1074\/jbc.M001436200","article-title":"Mechanism of inhibition of HIV-1 integrase by G-tetrad-forming oligonucleotides in\u00a0Vitro","volume":"275","author":"Jing","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.02.012_bib28","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.4049\/jimmunol.1300530","article-title":"Synthetic oligodeoxynucleotides containing suppressive TTAGGG motifs inhibit AIM2 inflammasome activation","volume":"191","author":"Kaminski","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib29","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1074\/jbc.M410868200","article-title":"Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells","volume":"280","author":"Kerkmann","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.02.012_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of Toll-like receptor 9 activation","volume":"5","author":"Krieg","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2016.02.012_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0166-3542(90)90064-E","article-title":"Dextran sulfate inhibits the fusion of influenza virus with model membranes, and suppresses influenza virus replication in\u00a0vivo","volume":"14","author":"Luscher-Mattli","year":"1990","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.02.012_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF01309663","article-title":"A\u00a0comparative study of the effect of dextran sulfate on the fusion and the in\u00a0vitro replication of influenza A and B, Semliki Forest, vesicular stomatitis, rabies, Sendai, and mumps virus","volume":"130","author":"Luscher-Mattli","year":"1993","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1189\/jlb.1202630","article-title":"Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions","volume":"73","author":"Marshall","year":"2003","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/j.gastro.2009.04.048","article-title":"Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry","volume":"137","author":"Matsumura","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2016.02.012_bib36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1126\/science.2452480","article-title":"Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells","volume":"240","author":"Mitsuya","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.02.012_bib37","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/JVI.74.4.1948-1960.2000","article-title":"Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120","volume":"74","author":"Moulard","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature08157","article-title":"Emergence and pandemic potential of swine-origin H1N1 influenza virus","volume":"459","author":"Neumann","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.02.012_bib39","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.02.012_bib40","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm1109-1253","article-title":"New prospects for the rational design of antivirals","volume":"15","author":"Nistal-Villan","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.02.012_bib41","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1128\/AAC.01003-13","article-title":"Nucleic acid polymers inhibit duck hepatitis B virus infection in\u00a0vitro","volume":"57","author":"Noordeen","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.02.012_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1099\/0022-1317-33-1-159","article-title":"Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action","volume":"33","author":"Palese","year":"1976","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0042-6822(74)90276-1","article-title":"Characterization of temperature sensitive influenza virus mutants defective in neuraminidase","volume":"61","author":"Palese","year":"1974","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.02.012_bib44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1073\/pnas.87.3.867","article-title":"G-DNA: a twice-folded DNA structure adopted by single-stranded oligo(dG) and its implications for telomeres","volume":"87","author":"Panyutin","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.02.012_bib45","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1093\/nar\/gkl867","article-title":"Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primates","volume":"34","author":"Puig","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2016.02.012_bib46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/A:1013282015121","article-title":"Fusion and infection of influenza and Sendai viruses as modulated by dextran sulfate: a comparative study","volume":"21","author":"Ramalho-Santos","year":"2001","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.antiviral.2016.02.012_bib47","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1074\/jbc.270.4.1754","article-title":"Suppression of human immunodeficiency virus type 1 activity in\u00a0vitro by oligonucleotides which form intramolecular tetrads","volume":"270","author":"Rando","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.02.012_bib48","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.vaccine.2008.02.001","article-title":"A\u00a0vaccine prepared from a non-pathogenic H7N7 virus isolated from natural reservoir conferred protective immunity against the challenge with lethal dose of highly pathogenic avian influenza virus in chickens","volume":"26","author":"Sakabe","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.02.012_bib49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/oli.2009.0210","article-title":"A\u00a0novel class of immune-stimulatory CpG oligodeoxynucleotides unifies high potency in type I interferon induction with preferred structural properties","volume":"20","author":"Samulowitz","year":"2010","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.antiviral.2016.02.012_bib50","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1128\/JVI.80.10.4740-4747.2006","article-title":"Virucidal activity of a GT-rich oligonucleotide against herpes simplex virus mediated by glycoprotein B","volume":"80","author":"Shogan","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib51","first-page":"93","article-title":"Development of vaccine strains of H5 and H7 influenza viruses","volume":"55","author":"Soda","year":"2008","journal-title":"Jpn. J. Vet. Res."},{"key":"10.1016\/j.antiviral.2016.02.012_bib52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4161\/hv.22950","article-title":"TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36\/AHG malaria vaccine in nonhuman primate models","volume":"9","author":"Tougan","year":"2013","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.antiviral.2016.02.012_bib53","doi-asserted-by":"crossref","first-page":"e30596","DOI":"10.1371\/journal.pone.0030596","article-title":"Synergistic TLR2\/6 and TLR9 activation protects mice against lethal influenza pneumonia","volume":"7","author":"Tuvim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.02.012_bib54","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1128\/JVI.01565-12","article-title":"Virulence determinants of pandemic A(H1N1)2009 influenza virus in a mouse model","volume":"87","author":"Uraki","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib55","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.50.4.1393-1401.2006","article-title":"Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation","volume":"50","author":"Vaillant","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.02.012_bib56","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1003749","article-title":"Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus","volume":"363","author":"van der Vries","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.02.012_bib57","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.4049\/jimmunol.166.4.2372","article-title":"Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs","volume":"166","author":"Verthelyi","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib58","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.4049\/jimmunol.168.4.1659","article-title":"CpG oligodeoxynucleotides as vaccine adjuvants in primates","volume":"168","author":"Verthelyi","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.02.012_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.addr.2008.12.008","article-title":"Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists","volume":"61","author":"Vollmer","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2016.02.012_bib60","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1086\/507548","article-title":"Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents","volume":"194","author":"Whitley","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.02.012_bib61","doi-asserted-by":"crossref","first-page":"33071","DOI":"10.1074\/jbc.M311662200","article-title":"Necessity of oligonucleotide aggregation for toll-like receptor 9 activation","volume":"279","author":"Wu","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.02.012_bib62","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.antiviral.2012.09.012","article-title":"Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains","volume":"96","author":"Yamada","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.02.012_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2014.09.002","article-title":"Dextran sulfate-resistant A\/Puerto Rico\/8\/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein","volume":"111","author":"Yamada","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.02.012_bib64","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1128\/AAC.37.7.1420","article-title":"Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification","volume":"37","author":"Yao","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.02.012_bib65","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1128\/JVI.01410-12","article-title":"Intranasal treatment with poly(I*C) protects aged mice from lethal respiratory virus infections","volume":"86","author":"Zhao","year":"2012","journal-title":"J.\u00a0Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T05:51:01Z","timestamp":1656222661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216300894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":65,"alternative-id":["S0166354216300894"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.02.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-like receptor 9 ligand D-type oligodeoxynucleotide D35 as a broad inhibitor for influenza A virus replication that is associated with suppression of neuraminidase activity","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}